Abstract
The apolipoprotein (Apo) E gene is known to be polymorphic. Three common alleles determine six phenotypes which can easily be detected by restriction fragment length polymorphism. We performed apo E genotyping in myocardial infarction survivors and healthy controls for the first time in the Turkish population. DNA was amplified by polymerase chain reaction (PCR) and the PCR product was digested with restriction enzymesHhaI to detect apo E2, E3, E4 and withTaqI to detect apo E1. Relative allele frequency for the patient group was found to be 0.91 for E3, 0.07 for E2, 0.02 for E4 and for the control group 0.875 for E3, 0.067 for E2, 0.058 for E4.
Similar content being viewed by others
References
Asawaka J, Takahashi N, Rosenbum BB, Neel JV. Two dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet 70:222–230;1985.
Assmann G, Schimtz RG, Menzel HJ, Schulte H. Apolipoprotein E polymorphism and coronary artery disease. Clin Chem 30:641–643;1984.
Assmann G, von Eckardstein A, Funke H, Rust S, Sandkamp M. Analysis of genetically determined structural polymorphisms in apolipoproteins E: B and (a). Curr Opin Lipidol 2:367–375;1991.
Crews DE, Kamboh MI, Bindon JR, Ferrell RE. Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa. Am J Anthropol 84:165–170;1991.
Cumming AM, Robertson F. Polymorphism at the apo E locus in relation to risk of coronary disease. Clin Genet 25:310–313;1984.
Eto M, Watanabe K, Ishii K. Reciprocal effects of apolipoprotein E alleles (e2 & e4) on plasma levels in normolipemic subjects. Clin Genet 29:477–484;1986.
Feussner G, Ziegler R. Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly 127 — Asp, Arg 158 — Cys) variant. Clin Invest 70:614–617;1992.
Feussner G, Funke H, Weng W, Assmann G, Lackner KJ, Ziegler R. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/null genotype. Eur J Clin Invest 22:599–608;1992.
Funke H, Rust S, Assmann G. Detection of apolipoprotein E variants by an oligonucleotide ‘melting procedure’. Clin Chem 32:1285–1289;1986.
Higuchi R. Simple and rapid preparation of samples for PCR. in: Erllich HA, ed. PCR Technology Principles and Application. New York, Stockton Press, 31–38; 1989.
Hill JS, Pritchard PH. Improved phenotyping of apolipoprotein E: Application to population frequency distribution. Clin Chem 36:1871–1874;1990.
Hixson JE, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage withHhaI. J Lipid Res 31:545–548;1990.
Kamboh MI, Ferrell RE, Kottke B. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apo E polymorphism. J Lipid Res 29:1535–1543;1988.
Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein polymorphism, low density lipoprotein cholesterol, and coronary artery disease. Clin Chem 32:778–781;1986.
Levy RI. Declining mortality in coronary heart disease. Arteriosclerosis 1:312–315;1981.
Mahley RW. Apolipoprotein E: cholesterol transport with expanding role in cell biology. Science 240:622–630;1988.
Mahley RW, Innerarity TL, Rall SC, Weisgraber KH, Taylor JM. Apolipoprotein E: Genetic variants provide insights into its structure and function. Curr Opin Lipidol 1:87–95;1990.
Main BF, Banfield DK, Jones PJ. Apolipoprotein E genotyping using polymerase chain reaction. N Z Med J 103:80–81;1990.
McDowall IFW, Wisdom GB, Trimble ER. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem 35:2070–2073;1989.
Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and hyperlipoproteinemia. Arteriosclerosis 3:310–315;1983.
Moriyama K, Sasaki J, Matsunaga A et al. Apolipoprotein E1 146-Glu with type III hyperlipoproteinemia. Biochim Biophys Acta 1128:58–64;1992.
Moriyama K, Sasaki J, Matsunaga A, et al. Apolipoprotein E1 Lys — 146 — Glu with type III hyperlipoproteinemia. Biochim Biophys Acta 1128:58–64;1992.
Rall SC, Mahley RW. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med 231:653–659;1992.
Tsuchiya S, Yamamouchi Y, Onuki M, et al. Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese. Intern Med 118:599–608;1993.
Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of Apo E genotype in a Japanese population. J Lab Clin Med 121:598–602;1993.
Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158–1159;1991.
Yamamura T, Dong LM, Yamamoto A. Apolipoprotein E polymorphism and coronary heart disease. Chin Med J 105:738–741;1992.
Zannis VI. Genetic polymorphism in human apolipoprotein E. Methods Enzymol 128:823–851;1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hergenc, G., Taga, Y., Emerk, K. et al. Apolipoprotein E genotyping in Turkish myocardial infarction survivors and healthy controls. J Biomed Sci 2, 46–49 (1995). https://doi.org/10.1007/BF02257924
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02257924